How To Supercharge RWE Generation In Phase IV Trials

For a fraction of the expense, digital trial solutions (such as eConsent, TeleVisits, and Connected Sensors) integration in conjunction with Real World Data (RWD) offer a resolution to conventional challenges encountered in Phase IV trials. This approach simultaneously captures pivotal endpoint data indispensable for LTFU studies and serves as input for shaping forthcoming protocol designs and enhancing trial efficiencies.

In this webinar, Musaddiq Khan, Head of Therapeutic Area Solutions at Medable, alongside Robert Zambon, Vice President of Transformational Design at Syneos Health, Joy Bhosai, Chief Executive Officer of Pluto Health, and Sam Bavery, Vice President of Growth at Medable, discuss their joint efforts in implementing patient-centric digital trial solutions that harness the potential of RWD, translating it into actionable Real-World Evidence (RWE) insights for a sponsoring client.

By the end of this presentation, viewers will be more equipped to optimize digital trial solutions in Phase 4 and LTFU studies through:

• Conversion of RWD into actionable RWE insights, serving as a guide for future trials.
• Enhancement of patient safety via remote monitoring and immediate access to real-time data.
• Strengthening of patient engagement and retention, leading to enhanced data quality.
• Utilization of shared study attributes to standardize study development and expedite deployment processes.